Search posts by category

Jul 13, 2020

Evolving & ever-changing ETFs – an AP’s perspective: the in-flows and out-flows of ETFs with Dave Nadig

Despite COVID-19 and unrest around the globe, this year has finally seen semi-transparent active ETF launches from American Century’s ActiveShares to Fidelity’s Active ETFs. Although there is uncertainty of what each day, week or month will look like in the new normal, one thing is for sure, the interest for gaining more knowledge about semi-transparent active ETFs is growing. Following the SS&C ALPS webinar on the subject, we sat down with ETF Trends’, Director of Research, Dave Nadig, to get an authorized participants’ (AP) perspective around the flows for these new models.

Jul 10, 2020

Product development – innovation remains the key to success

Despite the fact the markets have largely recovered most of their losses from late Q1, it is likely the rest of 2020 will remain challenging for passive and active managers alike. A variety of product wrappers, including traditional mutual funds, passive and smart beta ETFs, and SMAs will be tested. Already, there are once again calls to examine whether traditional mutual funds that invest in hard-to-trade assets such as high yield bonds should allow daily investor withdrawals.

Jul 9, 2020

Transitioning from a registered investment advisor to a multi-family office

The decision to transform from a registered investment advisory (RIA) business to a multi-family office (MFO) can be challenging. On the one hand, an MFO typically has fewer, but more profitable, clients, but catering to the needs and expectations of ultra-wealthy families means some key differences from a traditional RIA.

Jul 7, 2020

Evolving & ever-changing ETFs—considerations from an asset manager’s point of view

Asset managers are fortunate to have a number of fund structures to choose from to launch their various strategies, either within active or passive constructs. As ETFs have gained in popularity with investors for their low cost, tax-efficient, transparent and tradeable structures, asset managers have increasingly concentrated on the ETF wrapper for their new product launches. While the basic blocking and tackling of ETF management is very similar to other fund structures, managing a product that simultaneously trades on a listed exchange presents many new challenges for asset managers that may require additional expertise.

Jul 7, 2020

SS&C Algorithmics wins Risk Technology Awards 2020 Bank ALM system of the year

SS&C Algorithmics is pleased to share that we have won Bank ALM system of the year at the prestigious Risk Technology Awards 2020.

The SS&C Algorithmics ALM solution provides a next-generation risk system, designed with business-driven interfaces, and built on high-performance analytical engines that delivers uncompromising, comprehensive results.

Jul 6, 2020

Opportunities in European last-mile logistics

As customers adjusted to pandemic mitigation measures, online orders from western Europe across all retail segments jumped as much as 80% in the first two weeks of April 2020 as compared to the previous year. Experts think these buying habits may become permanent, as the range of products consumers are buying online has expanded to include essentials like groceries and over-the-counter medication.

Jul 2, 2020

SS&C’s Event Center Services: planning for post-pandemic operations

As companies consider planning for orders being lifted and operations to resume, assessing the projects and tasks that were pushed to the back-burner is becoming a priority. As those items are defined, deciding how to navigate the backlog is the next step. Do you use in-house resources who are already working hard to get back to business as usual? Is now the time to consider outsourcing those projects to a group that specializes in managing these types of events?

Jul 1, 2020

The role of efficient contact tracing in 2020 and beyond

According to a recent article in The Guardian, “As soon as a vaccine is approved, it’s going to be needed in vast quantities. In a best-case scenario, mass manufacture probably won’t arrive before 2021 – and many of the organisations in the Covid-19 vaccine race simply don’t have the necessary production capacity.”

RSS

Theme picker